Organization
Halozyme Therapeutics, Inc.
Topic
All Topics
People
Find news about people
Alumni
Find news on alumni of any org
Industries
Find news on a particular market
Your Contacts
Find news on your contacts
Sign up for free daily alerts on this feed:
By pressing Sign Up, you agree to our Terms of Use, Privacy Policy, and the LexisNexis Terms & Conditions

Follow

Change Feed
Halozyme Therapeutics, Inc.
... Halozyme Therapeutics, Inc. (NASDAQ: HALO), a biotechnology company developing novel oncology and drug-delivery therapies, today ...
... Financial Performance 8.8.3. Product Portfolio 8.8.2. ENHANZE Technology 8.8.1. Company Overview 8.8. Halozyme Therapeutics 8.7.5. Future Outlook 8.7.4. Recent Developments 8.7.3. Product Portfolio 8.7.2. FluidCrystal ...
... contrast significant profits were realized from positions in Agios, Novo Nordisk and Halozyme - and some of the position in Probiodrug was sold in response ...
... Biotechnology company Halozyme Therapeutics Inc (NASDAQ:HALO) said on Wednesday that it has successfully filed a Biologics ...
... Halozyme Therapeutics, Inc. (NASDAQ: HALO) today announced that the U.S. Food and Drug Administration (FDA) ...
... SAN DIEGO - Halozyme Therapeutics, Inc. (NASDAQ: HALO), a biotechnology company developing novel oncology and drug-delivery therapies, will ...
... Halozyme Therapeutics, Inc. (NASDAQ: HALO), a biotechnology company developing novel oncology and drug-delivery therapies, will ...
Subscribe now for full coverage on Halozyme Therapeutics, Inc.
Start My Free Trial